Literature DB >> 19337688

Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas.

Juan Martino1, Luc Taillandier, Sylvie Moritz-Gasser, Peggy Gatignol, Hugues Duffau.   

Abstract

BACKGROUND: To analyze the functional and oncological results after re-operation for recurrent WHO grade II Glioma located in eloquent regions.
METHOD: We reviewed a consecutive series of 19 patients with GIIG within functional areas who underwent two operations separated by at least 1 year. Intraoperative electrical stimulation mapping was used in all operations for recurrence and in 14 of the initial procedures. A specific rehabilitation was provided.
FINDINGS: At the first operation, we performed 14 subtotal and 5 partial resections. Eighteen patients returned to a normal socio-professional life. Nine patients received adjuvant treatment. At the second operation, we performed 1 total, 13 subtotal and 5 partial resections. Three patients with a preoperative neurological deficit improved, 13 remained unchanged, and 3 slight new deficits appeared. In 14 of the 17 patients with preoperative chronic epilepsy, the seizures were reduced or disappeared. Sixteen patients returned to a normal socio-professional life. Pathohistological examination showed that 11 tumours had progressed to high-grade glioma. The median time between the two operations was 4.1 years (range 1 to 7.8 years) and the median follow-up from initial diagnosis was 6.6 years (range 2.3 to 14.3 years). No deaths occurred during the follow-up period.
CONCLUSIONS: Repeat operations guided by intra-operative electrical stimulation is an efficacious treatment for recurrent grade II glioma in an eloquent area.

Entities:  

Mesh:

Year:  2009        PMID: 19337688     DOI: 10.1007/s00701-009-0232-6

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  23 in total

Review 1.  Awake surgery between art and science. Part II: language and cognitive mapping.

Authors:  Andrea Talacchi; Barbara Santini; Marilena Casartelli; Alessia Monti; Rita Capasso; Gabriele Miceli
Journal:  Funct Neurol       Date:  2013 Jul-Sep

Review 2.  Surgery of insular and paralimbic diffuse low-grade gliomas: technical considerations.

Authors:  Karine Michaud; Hugues Duffau
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

Review 3.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Authors:  Hugues Duffau; Luc Taillandier
Journal:  Neuro Oncol       Date:  2014-08-02       Impact factor: 12.300

Review 4.  Role of Functional Imaging Techniques to Assess Motor and Language Cortical Plasticity in Glioma Patients: A Systematic Review.

Authors:  S Cirillo; M Caulo; V Pieri; A Falini; A Castellano
Journal:  Neural Plast       Date:  2019-11-11       Impact factor: 3.599

Review 5.  Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.

Authors:  P D Delgado-López; E M Corrales-García; J Martino; E Lastra-Aras; M T Dueñas-Polo
Journal:  Clin Transl Oncol       Date:  2017-03-02       Impact factor: 3.405

6.  Resting functional connectivity in patients with brain tumors in eloquent areas.

Authors:  Juan Martino; Susanne M Honma; Anne M Findlay; Adrian G Guggisberg; Julia P Owen; Heidi E Kirsch; Mitchel S Berger; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

7.  Pushing the limits of glioma resection using electrophysiologic brain mapping.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

Review 8.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 9.  Seizure prognosis in brain tumors: new insights and evidence-based management.

Authors:  Charles J Vecht; Melissa Kerkhof; Alberto Duran-Pena
Journal:  Oncologist       Date:  2014-06-04

10.  Surgery of highly eloquent gliomas primarily assessed as non-resectable: risks and benefits in a cohort study.

Authors:  Sandro M Krieg; Lea Schnurbus; Ehab Shiban; Doris Droese; Thomas Obermueller; Niels Buchmann; Jens Gempt; Bernhard Meyer; Florian Ringel
Journal:  BMC Cancer       Date:  2013-02-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.